Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News Out

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon May 02, 2024 12:57pm

176 Views

Post# 36019841

RE:News Out

I think they are refering to BTD final Approval from FDA in 3rd Quarter. I believe, they will apply for PRE BTD this quarter and Formal BTD soon after and get an answer back within 60 Days. BTD approval cannot be earlier than 3rd quarter at best.

<< Previous

Bullboard Posts

Next >>

Osisko Development receives permits for Cariboo Gold Project